Christmas week started with stocks seeing lots of red as investors hit the exits amid a slew of worries.
Most notably, a spike in the number of omicron COVID-19 cases, which prompted several countries to initiate new restrictions, including lockdowns, ahead of the holiday. (As a reminder, the stock market will be closed Friday for Christmas.)
Additionally, over the weekend, news emerged that Senator Joe Manchin, a Democrat from West Virginia, will not support President Joe Biden's Build Back Better (BBB) bill, putting the nearly $2 trillion social infrastructure package in danger of not making it through Congress.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
"A failure to pass BBB has negative growth implications," says a team of economists at Goldman Sachs. As such, "we are lowering our real gross domestic product forecast for 2022: 2% in Q1 (vs. 3% prior), 3% in Q2 (vs. 3.5% prior), and 2.75% in Q3 (vs. 3% prior)."
Just two sectors finished in the green today – utilities (+0.09%) and consumer staples (+0.03%) – with financials (-1.9%) suffering the steepest loss. Energy was another notable decliner, slumping 1.2% as U.S. crude futures fell 3% to $68.61 per barrel.
When the closing bell mercifully sounded, the Dow Jones Industrial Average was down 1.2% at 34,932, the S&P 500 Index had given back 1.1% to 4,568 and the Nasdaq Composite was off 1.2% to 14,980.
Other news in the stock market today:
- The small-cap Russell 2000 slumped 1.6% to 2,139.
- Gold futures slipped 0.6% to settle at $1,794.60 an ounce.
- Oracle (ORCL) slid 5.1% after the enterprise software firm said it will buy medical records company Cerner (CERN, +0.8%) in an all-cash deal valued at roughly $28.3 billion in equity value. The acquisition is the biggest ever for Oracle and is expected to close in 2022. "We think that acquiring CERN would allow ORCL to gain a much larger foothold in the healthcare industry," says Jefferies analyst Brent Thill (Hold). "From a strategic perspective, CERN would bring a massive health records dataset to ORCL and allow ORCL to further expand on the apps business side, while CERN stands to benefit from ORCL's broad suite of front- and backoffice apps to help consolidate its software systems and make a deeper push into the healthcare industry."
- Moderna (MRNA) jumped 8.9% out of the gate after the biotechnology firm said a third booster shot of its COVID-19 vaccine is effective in protecting against the omicron variant. However, the shares moved lower as the session wore on, ending the day down 6.3%.
- Bitcoin rose 1.7% to $47,030.63. (Bitcoin trades 24 hours a day; prices reported here are as of 4 p.m.)
Is Tech Still a Good Bet in 2022?
Techs have taken a hit in the last week or so, but are still set to end the year as one of the best-performing sectors of 2021. At 27.3% gains year-to-date, the tech sector is running neck and neck with the financial sector (27.8%) and perched just behind energy (39.8%) and real estate (34.8%).
And looking ahead to 2022, there will be plenty of opportunities for growth in technology, says Tony DeSpirito, CIO of BlackRock's U.S. Fundamental Active Equities.
One specific area where he sees possibility is 5G technology. "Telecom companies will need to spend on upgrades and create new use cases for stimulating demand for 5G-powered technologies," he writes.
Additionally, he believes companies will continue to spend big on supporting both home and office systems in the new hybrid work environment. This is likely to benefit cloud stocks, which have benefited tremendously during the pandemic – and have a long runway of growth ahead of them.
Read on as we look at seven cloud stocks that could profit from substantial spending and growth in 2022 and beyond.
-
Stock Market Today: Stocks End Higher in Whipsaw SessionThe main indexes were volatile Thursday with Nvidia earnings in focus.
-
Trump Picks Dr. Oz as Head of Medicare and MedicaidPresident-elect Donald Trump picked Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services. Here's what to know about the former TV host.
-
Why Is Warren Buffett Selling So Much Stock?Berkshire Hathaway is dumping equities, hoarding cash and making market participants nervous.
-
Fed Cuts Rates Again: What the Experts Are SayingFederal Reserve The central bank continued to ease, but a new administration in Washington clouds the outlook for future policy moves.
-
If You'd Put $1,000 Into Google Stock 20 Years Ago, Here's What You'd Have TodayGoogle parent Alphabet has been a market-beating machine for ages.
-
Stock Market Today: Stocks Swing Lower After Fed's Jumbo Rate CutThe Federal Reserve caught plenty of folks off-guard with its jumbo-sized half-percentage point rate cut.
-
Fed Goes Big With First Rate Cut: What the Experts Are Saying
Federal Reserve A slowing labor market prompted the Fed to start with a jumbo-sized reduction to borrowing costs.
-
Stock Market Today: Dow Hits Record High Ahead of Fed MeetingAll eyes are on this Wednesday's Fed announcement, with expectations for a jumbo-sized rate cut rising.
-
Stock Market Today: Stocks Rise in Choppy Day for MarketsModerna was the worst S&P 500 stock today after the vaccine maker slashed its R&D budget.
-
Moderna Stock Plunges as Vaccine Maker Slashes R&D Budget: What to KnowModerna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.
